Finished fibrous structures and methods of their use and preparation

1. A method of locally, systemically, or locally and systemically, administering a therapeutically effective amount of an active pharmaceutical ingredient to a subject in need thereof comprising:

applying a garment that is a mechanically dewatered, finished, non-occlusive, pharmaceutical fibrous structure to the intact skin of the subject for a time sufficient to locally administer, systemically administer, or both locally and systemically administer the therapeutically effective amount of the active pharmaceutical ingredient to the subject,

the garment comprising natural fibers, manmade fibers, synthetic fibers, or a mixture thereof,

wherein the garment has been finished with a finishing composition that is a homogeneous dispersion comprising

an active pharmaceutical ingredient or a pharmaceutically acceptable salt thereof,

a solvent;

a surfactant;

optionally, a humectant; and

optionally, a permeation enhancer;

wherein the garment is finished by being caused to interact with the homogeneous dispersion by at least one of diffusion of the homogeneous dispersion into the garment fibers, deposition of the homogeneous dispersion onto the surfaces of the garment fibers, and deposition of the homogeneous dispersion onto the interstices between the garment fibers; and

wherein the dry weight of the mechanically dewatered, finished, non-occlusive, pharmaceutical fibrous structure is increased at least about 20% Add-on, as compared to the dry weight of the fibrous structure absent the finishing treatment.

2. The method of claim 1 wherein the active pharmaceutical ingredient is lidocaine, prilocaine, bupivacaine, mepivacaine, ropivacaine, articaine, tetracaine, capsaicin, diclofenac, menthol, methyl salicylate, salicylic acid, scopolamine, nitroglycerin, clonidine, estradiol, estradiol/norethidrone, ethinyl estradiol/norelgestromin, estradiol/levonorgestrel fentanyl, nicotine, testosterone, oxybutynin, prilocaine, methylphenidate, betamethasone, buprenorphine, triclocarban, acyclovir, adapalene, allantoin, benzocaine, bexarotene, brimonidine, calcipotriene, calcitriol, ciclopirox, clindamycin, clobetasol, dapsone, diphenhydramine, doxepin, econazole, fluocinolone, fluticasone, halobetasol, hydrocortisone, imiquimod, ingenol, ivermectin, ketoconazole, loteprednol, luliconazole, mafenide, methyl salicylate, metronidazole, miconazole, minoxidil, mometasone, mupirocin, neomycin, nystatin, penciclovir, phenylephedrine, pimecrolimus, pramoxine, selenium, sulconazole, sulfacetamide, tacrolimus, tavaborole, tetracycline, tioconazole, tretinoin, triamcinolone, triclosan, selegiline, rotigotine, rivastigmine, terbinafine, clotrimazole, detomidine, medetomidine, dexmedetomidine, or a combination thereof.

3. The method of claim 1 , wherein the garment is applied to the subject's intact skin for a time period that is between about 1 hour and about 72 hours.

4. The method of claim 1 , wherein the therapeutically effective amount is administered to the subject throughout the time period.

5. The method of claim 1 , wherein the garment is applied to the subject's intact skin continuously throughout the time period.

6. The method of claim 1 , wherein the garment is applied to the subject's intact skin intermittently throughout the time period.

7. The method of claim 1 , for the treatment of pain.

8. The method of claim 7 , wherein the pain is neuropathic pain.

9. The method of claim 7 , wherein the pain is postherpetic neuralgia or painful diabetic neuropathy, pain associated with chemotherapy, pain associated with HIV, erythromelalgia, pain associated with osteoarthritis, or lower back pain.

10. The method of claim 1 , for the treatment of a microbial infection or a fungal infection.

11. The method of claim 1 , for the treatment of an allergy, atopic dermatitis, psoriasis, chronic inflammation, or acute inflammation.

12. The method of claim 1 , wherein the garment is finished by being caused to interact with the homogeneous dispersion by diffusion of the homogeneous dispersion into the garment fibers.

13. The method of claim 1 , wherein the garment is finished by being caused to interact with the homogeneous dispersion by deposition of the homogeneous dispersion onto the surfaces of the garment fibers.

14. The method of claim 1 , wherein the garment is finished by being caused to interact with the homogeneous dispersion by deposition of the homogeneous dispersion onto the interstices between the garment fibers.

15. The method of claim 1 , wherein the garment is in the form of a glove, sock, shirt, pant, cap, underpant, brassier, or band.

16. The method of claim 15 , wherein the band is an armband, legband, headband, wristband, backbelt, kneeband, ankleband, elbowband, or neckband.

17. The method of claim 1 , wherein the garment is in the form of a sock.

18. The method of claim 1 , wherein the garment is in the form of a t-shirt.

19. The method of claim 1 , wherein the garment is in the form of a glove.

20. The method of claim 1 , wherein the garment is in the form of a band.